| Literature DB >> 29972464 |
Emanuelle Malzac Freire de Santana1, Karen Krystine Gonçalves de Brito1, Ester Missias Vilaverde Antas1, Jordana de Almeida Nogueira1, Oriana Deyze Correia Paiva Leadebal1, Mirian Alves da Silva2, Marta Miriam Lopes Costa1, Maria Júlia Guimarães Oliveira Soares1.
Abstract
Hansen's disease is probably the human disease that causes more damage. The aim of this study was to investigate the association between the occurrence of the association of grade 1 and 2 physical disabilities in Hansen's disease, as well as implications of joint analysis and strength of association with independent demographic and clinical variables. This is a quantitative, descriptive, retrospective, population-based and documentary study developed from 2009 to 2014 in a Hansen's disease reference center in Joao Pessoa, PB. It involved 414 medical records, the diagnosis and discharge data on socio-demographic, clinical and simplified neurological evaluation variables. Data were analyzed using descriptive (absolute frequency and percentage) and inferential (Chi-Square and Prevalence Ratio (PR) statistics techniques. Both in the diagnosis and discharge, low education level, multibacillary classification and presence of affected nerves were statistically associated to the development of disabilities (p <0.05). The gender showed association only at discharge (p <0.05). Male gender, low education level, multibacillary classification and presence of affected nerves were identified as factors associated with the development of disabilities, and the individuals were more likely to develop disabilities at discharge. There is a need for development of surveillance actions for the population group identified for the detection and early treatment of the disease. Higher chances of developing disabilities in the discharge period makes the promotion of guidelines that standardize the care of these individuals imperative.Entities:
Mesh:
Year: 2018 PMID: 29972464 PMCID: PMC6029852 DOI: 10.1590/s1678-9946201860027
Source DB: PubMed Journal: Rev Inst Med Trop Sao Paulo ISSN: 0036-4665 Impact factor: 1.846
– Association of disability stage, demographic and clinical variables at the time of diagnosis. Joao Pessoa, 2016
| Demographic and clinic variables | Total | Incapacity stage | PR** (IC. 95%) | ||||
|---|---|---|---|---|---|---|---|
| Stage (1 or 2) | Stage 0 | ||||||
| n | % | n | % | N | % | ||
|
| |||||||
| Male | 243 | 100 | 103 | 42,4 | 140 | 57,6 | |
| Female | 171 | 100 | 65 | 38,0 | 106 | 62,0 | 1,115 (0,876 - 1,419) |
|
|
|
|
|
|
|
| |
|
| |||||||
| Low | 222 | 100 | 106 | 47,7 | 116 | 52,3 | |
| Moderate/High | 192 | 100 | 62 | 32,3 | 130 | 67,7 | 1,479 (1,155 - 1,892) |
|
|
|
|
|
|
|
| |
|
| |||||||
| Paucibacillary | 163 | 100 | 36 | 22,1 | 127 | 77,9 | |
| Multibacillary | 251 | 100 | 132 | 52,6 | 119 | 47,4 | 2,381 (1,744 - 3,251) |
|
|
|
|
|
|
|
| |
(*) Significant association ≤ 0,05. (**) PR = Prevalence Ratio.
– Association of the disability stage, demographic and clinical variables at discharge. Joao Pessoa, 2016
| Demographic and clinic variables | Total | Incapacity stage | PR** (IC. 95%) | ||||
|---|---|---|---|---|---|---|---|
| Stage (1 or 2) | Stage 0 | ||||||
| n | % | N | % | n | % | ||
|
| |||||||
| Male | 243 | 100 | 101 | 41,6 | 142 | 58,4 | |
| Female | 171 | 100 | 54 | 31,6 | 117 | 68,4 | 1,316 (1,009 - 1,718) |
|
|
|
|
|
|
|
| |
|
| |||||||
| Low | 222 | 100 | 105 | 47,3 | 117 | 52,7 | |
| Moderate/High | 192 | 100 | 50 | 26 | 142 | 74 | 1,816 (1,378 - 2,393) |
|
|
|
|
|
|
|
| |
|
| |||||||
| Paucibacillary | 163 | 100 | 28 | 17,2 | 135 | 82,8 | |
| Multibacillary | 251 | 100 | 127 | 50,6 | 124 | 49,4 | 2,946 (2,058 - 4,216) |
|
|
|
|
|
|
|
| |
(*) Significant association ≤ 0,05. (**) PR = Prevalence Ratio.
– Association of disability stage and the affected nerves at the time of diagnosis and at the cure discharge period. Joao Pessoa, 2016
| Affected nerves (1) | Total | Incapacity Stage | X2Association test | PR** (IC. 95%) | ||||
|---|---|---|---|---|---|---|---|---|
| Stage – (1 ou 2) | Grau – 0 | Sig. p-valor | ||||||
| n | % | n | % | N | % | |||
|
| p(1)=0,000* | |||||||
| Diagnosis | 118 | 100 | 77 | 65,3 | 41 | 34,7 | 2,123 (1,711 - 2,634) | |
| Discharge | 84 | 100 | 55 | 65,5 | 29 | 34,5 | 2,161 (1,724 - 2,707) | |
|
| p(1)=0,000* | |||||||
| Diagnosis | 60 | 100 | 40 | 66,7 | 20 | 33,3 | 1,844 (1,470 - 2,312) | |
| Discharge | 34 | 100 | 24 | 70,6 | 10 | 29,4 | 2,048 (1,583 - 2,649) | |
|
| p(1)=0,000* | |||||||
| Diagnosis | 95 | 100 | 70 | 73,7 | 25 | 26,3 | 2,398 (1,956 - 2,941) | |
| Discharge | 34 | 100 | 24 | 70,6 | 10 | 29,4 | 2,048 (1,583 - 2,649) | |
|
| p(1)=0,000* | |||||||
| Diagnosis | 83 | 100 | 56 | 67,5 | 27 | 32,5 | 1,994 (1,613 - 2,465) | |
| Discharge | 56 | 100 | 44 | 78,6 | 12 | 21,4 | 2,534 (2,062 - 3,115) | |
|
| p(1)=0,000* | |||||||
| Diagnosis | 102 | 100 | 71 | 69,6 | 31 | 30,4 | 2,239 (1,816 - 2,760) | |
| Discharge | 80 | 100 | 62 | 77,5 | 18 | 22,5 | 2,783 (2,258 - 3,431) | |
(*) Significant association ≤ 0,05. (**) PR = Prevalence Ratio.